HUDSON, N.H., Oct. 3, 2011 /PRNewswire/ -- Atrium Medical
Corporation, announced today that it has signed a definitive
agreement to be acquired by GETINGE GROUP (STO: GETIB) of
Sweden and its subsidiary, MAQUET
Cardiovascular, a global leading provider of cardiovascular
technologies for $680 million.
Atrium is a leader in medical device technologies for
interventional cardiology and radiology, chest trauma care and
thoracic drainage, vascular surgery, and general surgery.
Atrium will operate as an independent, self-contained
business unit of MAQUET Cardiovascular and will continue to be led
by current Atrium President, Trevor
Carlton.
"MAQUET Cardiovascular's heritage and global leadership in the
interventional cardiology, vascular surgery and cardiopulmonary
space provides us the resources necessary to continue to grow our
business and better serve our customers around the world," said
Trevor Carlton, President, Atrium
Medical. "We believe the similarities in our cultures and
business focus, coupled with our ability to continue to work
independently will allow our sales team, researchers and scientists
to unlock the value of the core technologies that have driven our
success to date."
"The acquisition of Atrium is an excellent strategic fit with
our long-term business goals as Atrium's robust product line
complements MAQUET Cardiovascular's existing therapy options and
provides additional solutions for the customers that we serve,"
said Christian Keller, President and
Chief Executive Officer of MAQUET Cardiovascular. "Like
MAQUET, innovation is at the core of Atrium's business and we
believe that this acquisition will leverage the scientific and
technological advances across both organizations and enhance our
ability to deliver ground-breaking solutions to our customers and
patients worldwide."
BofA Merrill Lynch acted as exclusive financial advisor to
Atrium Medical Corporation in connection with the transaction and
Latham & Watkins LLP acted as legal counsel.
The transaction is expected to close in the fourth quarter of
2011, subject to U.S. Federal Trade Commission (FTC) approval.
About Atrium
Atrium's vast expertise in medical device technologies for the
treatment of coronary and vascular disease, chest trauma, hernia
and soft tissue injury has brought a number of breakthrough
advances in several diversified healthcare markets including
interventional cardiology and radiology, chest trauma care and
thoracic drainage, vascular surgery, and general surgery.
Maintaining a commitment to the latest ISO13485 Quality Standards,
state-of-the-art manufacturing and automation, cell biology and
biomaterial discovery programs, Atrium continues to excel in those
healthcare segments that require more advanced surgical
intervention for improvements in patient outcomes. For more
information please visit www.atriummed.com.
About MAQUET
As a trusted partner for hospitals and clinicians since 1838,
MAQUET is a global leader in medical systems that advance surgical
interventions, cardiovascular procedures and critical care. MAQUET
develops and designs innovative products and therapeutic
applications for the operating room, hybrid OR/cath lab, intensive
care unit and patient transport within acute care hospitals,
improving outcomes and quality of life for patients.
Cardiovascular specialties include intra-aortic balloon
counterpulsation (IABC) therapy for cardiac assist; coronary artery
bypass surgery; aortic and peripheral vascular surgery; and
extracorporeal circulation. The Critical Care portfolio includes
market-leading intensive care ventilators and anesthesia machines.
MAQUET also equips Surgical Workplaces with critical
infrastructure, such as flexible room design for OR and ICU; OR
tables; lights and ceiling supply units; and OR integration for
image data management.
MAQUET is a subsidiary of the publicly listed Swedish GETINGE
GROUP. In 2010, MAQUET generated nearly half of the company's
annual revenue of $3.2 billion. The
company has 12,000 employees worldwide, including 5,000 employees
in 36 international sales and service organizations, as well as a
network of more than 250 sales representatives. For more
information please visit www.maquet.com and
www.getingegroup.com.
About Getinge
GETINGE GROUP is a leading global provider of products and
systems that contribute to quality enhancement and cost efficiency
within healthcare and life sciences. GETINGE GROUP operates under
the three brands of ArjoHuntleigh, GETINGE and MAQUET.
ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control within
healthcare and contamination prevention within life sciences.
MAQUET specializes in solutions, therapies and products for
surgical interventions and intensive care.
The information is such that Getinge AB must disclose in
accordance with the Swedish Securities Market Act and/or the
Financial Instruments Trading Act.
SOURCE Atrium Medical Corporation
